CD26-antigen-inhibitorsBullous pemphigoid: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82620-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：77 / 77

相关论文

共 50 条

[11] AntidiabeticsBullous pemphigoid: 3 case reports
Reactions Weekly, 2016, 1605 (1) : 20 - 20
[12] AntihyperglycaemicsBullous pemphigoid: 9 case reports
Reactions Weekly, 2018, 1694 (1) : 34 - 34
[13] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2021, 1872 (1) : 286 - 286
[14] AntihyperglycaemicsBullous pemphigoid: 12 case reports
Reactions Weekly, 2018, 1710 (1) : 36 - 36
[15] TozinameranBullous pemphigoid: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 406 - 406
[16] NemolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2024, 2029 (1) : 507 - 507
[17] VildagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2018, 1723 (1) : 294 - 294
[18] PembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2018, 1722 (1) : 277 - 277
[19] FurosemideBullous pemphigoid: 2 case reports
Reactions Weekly, 2019, 1769 (1) : 215 - 215
[20] AntihyperglycaemicsBullous pemphigoid: 18 case reports
Reactions Weekly, 2020, 1817 (1) : 36 - 36

← 1 2 3 4 5 →